资讯
6 小时on MSN
The FDA announced a policy shift for COVID-19 vaccine approvals to focus on Americans considered high-risk of contracting the ...
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to ...
In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
China on Sunday announced anti-dumping duties as high as 74.9% on imports of POM copolymers, a type of engineering plastic, ...
The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.
Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are ...
The decision means many Americans without underlying conditions may not have access to updated shots this fall."I think we ...
4 小时on MSN
The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans, a move that may limit ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果